Navigation mit Access Keys

Search


Biozentrum is part of two BRCCH Multi-Investigator Projects

Precision Microbiota Engineering for Child Health The project “Precision Microbiota Engineering for Child Health”, headed by Prof. Emma Wetter Slack of the ETH Zurich, aims to modify the microbiota of individuals with inborn…


T3 Pharma qualifies for BaseLaunch funding program

The BaseLaunch program was launched in 2017 as an initiative of BaselArea.swiss, the office for business promotion for Northwestern Switzerland, with the aim of strengthening the start-up scene in the Basel region and…


Michael Hall receives the Frontiers of Knowledge Award

Today, the BBVA Foundation announced that Prof. Michael Hall from the Biozentrum of the University of Basel and Prof. David Sabatini from the MIT, USA, have been awarded the Frontiers of Knowledge Award in the category…


SNSF Starting Grant for Yuping Li

With the renowned Starting Grants, the SNSF honors excellent young researchers for their innovative research and supports them in consolidating their own research program. Yuping Li is one of the top young researchers to…


Biozentrum again part of the largest EU-funded research project on autism

In 2012, the "European Autism Interventions - A Multicentre Study for Developing New Medications" (EU-AIMS) was launched as a collaboration for research for the treatment of autism. The aim of this collaboration is to…


German pharma company acquires Biozentrum start-up for 450 million Swiss francs

T3 Pharmaceuticals (“T3 Pharma”) was founded in 2015 as a spin-off of the Biozentrum of the University of Basel. The company focuses on bacterial therapies for the treatment of solid tumors. The Basel-based biotech company’s…


Lethal combination: Drug cocktail turns off the “juice” to cancer cells

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the treatment of diabetes is too low to inhibit cancer growth. The…


ERC Starting Grant for Physicist David Brückner

With its Starting Grant, the ERC supports outstanding young researchers who lay the foundation for an independent research program with their innovative projects. One of this year’s awardees is physicist Prof. David…


Therapy for muscular dystrophy: A new start-up at the Biozentrum

Congenital muscular dystrophy is a rare hereditary disease which cannot be cured. The more than 30 known forms of this neuromuscular disease differ in the type of genetic defect and in the severity of disease progression.…


New discovery reveals how diatoms capture CO2 so effectively

Diatoms are too small to see with the naked eye, yet they are one of the most productive algae species in the ocean and play an important role in the global carbon cycle. Using photosynthesis, they absorb large amounts of…